Cutaneous malignant melanoma is the most aggressive form of skin cancer with an
extremely poor survival rate for the patients diagnosed with locally invasive and metastatic …

Earlier identification of aggressive melanoma remains a goal in the field of melanoma
research. With new targeted and immune therapies that have revolutionized the care of …

Melanoma is the most devastating form of skin cancer and represents a leading cause of
cancer death, particularly in young adults. As even relatively small melanomas can readily …

In an era of personalized medicine, disease specific biomarkers play an increasing role in
the stratification of high-risk patient groups. Cutaneous malignant melanoma is the most …

Melanoma, which is an aggressive skin cancer, is currently the fifth and seventh most
common cancer in men and women, respectively. The American Cancer Society reported …

The incidence of cutaneous malignant melanoma has rapidly increased in recent years in all
parts of the world, and melanoma is a leading cause of cancer death. As even relatively …

Cutaneous melanoma (CM) is a malignant tumor formed from pigment-producing cells
called melanocytes. It is one of the most aggressive and fatal forms of skin malignancy. In …

Despite enormous international efforts, skin melanoma is still a major clinical challenge.
Melanoma takes a top place among the most common cancer types and it has one of the …

Melanoma is a lethal melanocytic neoplasm. Unfortunately, the histological diagnosis can
be difficult at times. Distinguishing ambiguous melanocytic neoplasms that are benign nevi …

In less than 10 years, melanoma treatment has been revolutionized with the approval of
tyrosine kinase inhibitors and immune checkpoint inhibitors, which have been shown to …